Isthmus Partners’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-15,105
Closed -$687K 295
2017
Q4
$687K Hold
15,105
0.19% 97
2017
Q3
$501K Sell
15,105
-17,209
-53% -$701K 0.14% 104
2017
Q2
$1.31M Sell
32,314
-4,669
-13% -$145K 0.38% 45
2017
Q1
$745K Buy
36,983
+239
+0.7% +$5.05K 0.22% 81
2016
Q4
$848K Sell
36,744
-1,259
-3% -$27K 0.26% 70
2016
Q3
$775K Buy
38,003
+11
+0% +$222 0.25% 65
2016
Q2
$713K Sell
37,992
-979
-3% -$18K 0.23% 67
2016
Q1
$698K Buy
38,971
+82
+0.2% +$1.4K 0.23% 69
2015
Q4
$667K Buy
38,889
+1,763
+5% +$29.6K 0.23% 72
2015
Q3
$598K Buy
37,126
+252
+0.7% +$4.23K 0.22% 72
2015
Q2
$637K Buy
36,874
+1,009
+3% +$16.9K 0.21% 76
2015
Q1
$592K Buy
35,865
+985
+3% +$15.3K 0.2% 77
2014
Q4
$501K Buy
+34,880
New +$470K 0.17% 91

Other funds holding PETS

Isthmus Partners's PETS Position: Q1 2018 in Review

Isthmus Partners sold out of PetMed Express (PETS) in Q1 2018, closing a stake of 15,105 shares — an estimated $687K sold.

Isthmus Partners first reported a position in PETS in Q4 2014 and held it in 13 quarters. The position peaked at $1.31M in Q2 2017. 205 funds tracked by Wall St. Rank hold PETS as of Q1 2018.

  • Isthmus Partners reported no remaining PetMed Express position as of Q1 2018 after selling out during the quarter.
  • Isthmus Partners sold 15,105 PetMed Express shares in Q1 2018, an estimated $687K.
  • Isthmus Partners first reported a position in PetMed Express in Q4 2014 and held it in 13 quarters.
  • Isthmus Partners's PetMed Express position peaked at $1.31M in Q2 2017.
  • 205 funds tracked by Wall St. Rank held PetMed Express as of Q1 2018.

Based on Isthmus Partners's 13F filing for Q1 2018, filed 11 May 2018.